Rilvegostomig, Azd6750
Renal Cell Carcinoma, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, High Grade Serous Ovarian Carcinoma, Squamous Cell Carcinoma (Skin), Gastric Cancer/Gastroesophageal Junction Cancer
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors